Loading the security overview…
Where the tokens are
First the companies classified under the same themes, most themes in common first; then the ones investors most often look at alongside BSX. A peer with a tokenized version links to its own page, where every issuer that wraps it is listed.
| Company | Shared themes | Market cap | P/E | P/S | EV/EBITDA | ROE | F-Score | Altman zone |
|---|---|---|---|---|---|---|---|---|
| — | $62.65B | 17.1 | 3.0 | 12.5 | 14.7% | 7/9 | safe | |
| Cardiovascular DevicesNeuromodulation & Neurology | $4.3B | 33.5 | 2.3 | 16.4 | 7.5% | 7/9 | safe | |
| Cardiovascular DevicesNeuromodulation & Neurology | $4.12B | 21.8 | 2.8 | 16.2 | 14.2% | 5/9 | safe | |
| Cardiovascular Devices | $167.31B | 30.8 | 3.6 | 18.1 | 10.6% | 6/9 | safe | |
| Cardiovascular Devices | $110.57B | 21.1 | 3.0 | 13.6 | 10.4% | 7/9 | safe | |
| Cardiovascular Devices | $49.1B | 48.9 | 7.5 | 23.6 | 9.5% | 6/9 | safe | |
| Cardiovascular Devices | $12.53B | 78.0 | 8.3 | 60.4 | 10.5% | 7/9 | safe | |
| Cardiovascular Devices | $5.14B | 35.3 | 3.3 | 16.7 | 8.7% | 7/9 | safe | |
| Cardiovascular Devices | $4.25B | — | 20.1 | -62.5 | −42.3% | — | safe | |
| Cardiovascular Devices | $2.73B | 258.3 | 4.8 | 77.6 | 2.0% | 5/9 | safe | |
| Neuromodulation & Neurology | $2.34B | — | 9.3 | -376.6 | −13.1% | 4/9 | safe | |
| Neuromodulation & Neurology | $2.05B | 15.2 | 2.3 | 26.9 | 16.4% | 6/9 | safe | |
| Neuromodulation & Neurology | $1.85B | — | 2.6 | -14.2 | −43.9% | 3/9 | distress | |
| Cardiovascular Devices | $1.83B | 27.9 | 7.0 | 22.5 | 15.6% | 6/9 | safe | |
| Cardiovascular Devices | $1.62B | — | 15.1 | -12.1 | −67.4% | 3/9 | safe |
Figures describe Boston Scientific shares, not any token. From theme classifications, Massive's related companies and the latest ratios and scores. Ratios are trailing, each as of its own latest filing. Peers are for comparison, not a list of alternatives to buy.